 | • レポートコード：MRC2-11QY11814 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は子宮内膜がんのグローバル市場について調査・分析したレポートです。種類別（子宮摘出術、放射線療法、ホルモン療法、化学療法）市場規模、用途別（病院、クリニック、婦人科センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別子宮内膜がんの競争状況、市場シェア ・世界の子宮内膜がん市場：種類別市場規模 2015年-2020年（子宮摘出術、放射線療法、ホルモン療法、化学療法） ・世界の子宮内膜がん市場：種類別市場規模予測 2021年-2026年（子宮摘出術、放射線療法、ホルモン療法、化学療法） ・世界の子宮内膜がん市場：用途別市場規模 2015年-2020年（病院、クリニック、婦人科センター、その他） ・世界の子宮内膜がん市場：用途別市場規模予測 2021年-2026年（病院、クリニック、婦人科センター、その他） ・北米の子宮内膜がん市場分析：米国、カナダ ・ヨーロッパの子宮内膜がん市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの子宮内膜がん市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の子宮内膜がん市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの子宮内膜がん市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Johnson & Johnson、Boston Scientific、GE、Karl Storz、Koninklijke Philips、Celgene、Lupin、LiNA Medical、Bayer AG、Cooper Surgical、Hologic ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It is the result of the abnormal growth of cells that have the ability to invade or spread to other parts of the body. The first sign is most often vaginal bleeding not associated with a menstrual period. Other symptoms include pain with urination, pain during sexual intercourse, or pelvic pain. Endometrial cancer occurs most commonly after menopause.
The endometrial cancer market is dominated by North America owing to the rising prevalence of breast cancer.
Market Analysis and Insights: Global Endometrial Cancer Market
The global Endometrial Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Endometrial Cancer Scope and Market Size
Endometrial Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Endometrial Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Johnson & Johnson
Boston Scientific
GE
Karl Storz
Koninklijke Philips
Celgene
Lupin
LiNA Medical
Bayer AG
Cooper Surgical
Hologic
Market segment by Type, the product can be split into
Hysterectomy Techniques
Radiation
Hormone Therapy
Chemotherapy
Market segment by Application, split into
Hospitals
Clinics
Gynecology Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Endometrial Cancer Revenue
1.4 Market by Type
1.4.1 Global Endometrial Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hysterectomy Techniques
1.4.3 Radiation
1.4.4 Hormone Therapy
1.4.5 Chemotherapy
1.5 Market by Application
1.5.1 Global Endometrial Cancer Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Gynecology Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Endometrial Cancer Market Perspective (2015-2026)
2.2 Global Endometrial Cancer Growth Trends by Regions
2.2.1 Endometrial Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Endometrial Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Endometrial Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Endometrial Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Endometrial Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Endometrial Cancer Players by Market Size
3.1.1 Global Top Endometrial Cancer Players by Revenue (2015-2020)
3.1.2 Global Endometrial Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Endometrial Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Endometrial Cancer Market Concentration Ratio
3.2.1 Global Endometrial Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Endometrial Cancer Revenue in 2019
3.3 Endometrial Cancer Key Players Head office and Area Served
3.4 Key Players Endometrial Cancer Product Solution and Service
3.5 Date of Enter into Endometrial Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Endometrial Cancer Historic Market Size by Type (2015-2020)
4.2 Global Endometrial Cancer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Endometrial Cancer Market Size by Application (2015-2020)
5.2 Global Endometrial Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Endometrial Cancer Market Size (2015-2020)
6.2 Endometrial Cancer Key Players in North America (2019-2020)
6.3 North America Endometrial Cancer Market Size by Type (2015-2020)
6.4 North America Endometrial Cancer Market Size by Application (2015-2020)
7 Europe
7.1 Europe Endometrial Cancer Market Size (2015-2020)
7.2 Endometrial Cancer Key Players in Europe (2019-2020)
7.3 Europe Endometrial Cancer Market Size by Type (2015-2020)
7.4 Europe Endometrial Cancer Market Size by Application (2015-2020)
8 China
8.1 China Endometrial Cancer Market Size (2015-2020)
8.2 Endometrial Cancer Key Players in China (2019-2020)
8.3 China Endometrial Cancer Market Size by Type (2015-2020)
8.4 China Endometrial Cancer Market Size by Application (2015-2020)
9 Japan
9.1 Japan Endometrial Cancer Market Size (2015-2020)
9.2 Endometrial Cancer Key Players in Japan (2019-2020)
9.3 Japan Endometrial Cancer Market Size by Type (2015-2020)
9.4 Japan Endometrial Cancer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Endometrial Cancer Market Size (2015-2020)
10.2 Endometrial Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Endometrial Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Endometrial Cancer Market Size by Application (2015-2020)
11 India
11.1 India Endometrial Cancer Market Size (2015-2020)
11.2 Endometrial Cancer Key Players in India (2019-2020)
11.3 India Endometrial Cancer Market Size by Type (2015-2020)
11.4 India Endometrial Cancer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Endometrial Cancer Market Size (2015-2020)
12.2 Endometrial Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Endometrial Cancer Market Size by Type (2015-2020)
12.4 Central & South America Endometrial Cancer Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Endometrial Cancer Introduction
13.1.4 Pfizer Revenue in Endometrial Cancer Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Endometrial Cancer Introduction
13.2.4 Johnson & Johnson Revenue in Endometrial Cancer Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Boston Scientific
13.3.1 Boston Scientific Company Details
13.3.2 Boston Scientific Business Overview
13.3.3 Boston Scientific Endometrial Cancer Introduction
13.3.4 Boston Scientific Revenue in Endometrial Cancer Business (2015-2020)
13.3.5 Boston Scientific Recent Development
13.4 GE
13.4.1 GE Company Details
13.4.2 GE Business Overview
13.4.3 GE Endometrial Cancer Introduction
13.4.4 GE Revenue in Endometrial Cancer Business (2015-2020)
13.4.5 GE Recent Development
13.5 Karl Storz
13.5.1 Karl Storz Company Details
13.5.2 Karl Storz Business Overview
13.5.3 Karl Storz Endometrial Cancer Introduction
13.5.4 Karl Storz Revenue in Endometrial Cancer Business (2015-2020)
13.5.5 Karl Storz Recent Development
13.6 Koninklijke Philips
13.6.1 Koninklijke Philips Company Details
13.6.2 Koninklijke Philips Business Overview
13.6.3 Koninklijke Philips Endometrial Cancer Introduction
13.6.4 Koninklijke Philips Revenue in Endometrial Cancer Business (2015-2020)
13.6.5 Koninklijke Philips Recent Development
13.7 Celgene
13.7.1 Celgene Company Details
13.7.2 Celgene Business Overview
13.7.3 Celgene Endometrial Cancer Introduction
13.7.4 Celgene Revenue in Endometrial Cancer Business (2015-2020)
13.7.5 Celgene Recent Development
13.8 Lupin
13.8.1 Lupin Company Details
13.8.2 Lupin Business Overview
13.8.3 Lupin Endometrial Cancer Introduction
13.8.4 Lupin Revenue in Endometrial Cancer Business (2015-2020)
13.8.5 Lupin Recent Development
13.9 LiNA Medical
13.9.1 LiNA Medical Company Details
13.9.2 LiNA Medical Business Overview
13.9.3 LiNA Medical Endometrial Cancer Introduction
13.9.4 LiNA Medical Revenue in Endometrial Cancer Business (2015-2020)
13.9.5 LiNA Medical Recent Development
13.10 Bayer AG
13.10.1 Bayer AG Company Details
13.10.2 Bayer AG Business Overview
13.10.3 Bayer AG Endometrial Cancer Introduction
13.10.4 Bayer AG Revenue in Endometrial Cancer Business (2015-2020)
13.10.5 Bayer AG Recent Development
13.11 Cooper Surgical
10.11.1 Cooper Surgical Company Details
10.11.2 Cooper Surgical Business Overview
10.11.3 Cooper Surgical Endometrial Cancer Introduction
10.11.4 Cooper Surgical Revenue in Endometrial Cancer Business (2015-2020)
10.11.5 Cooper Surgical Recent Development
13.12 Hologic
10.12.1 Hologic Company Details
10.12.2 Hologic Business Overview
10.12.3 Hologic Endometrial Cancer Introduction
10.12.4 Hologic Revenue in Endometrial Cancer Business (2015-2020)
10.12.5 Hologic Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Endometrial Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Endometrial Cancer Revenue
Table 3. Ranking of Global Top Endometrial Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Endometrial Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hysterectomy Techniques
Table 6. Key Players of Radiation
Table 7. Key Players of Hormone Therapy
Table 8. Key Players of Chemotherapy
Table 9. Global Endometrial Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Endometrial Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Endometrial Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Endometrial Cancer Market Share by Regions (2015-2020)
Table 13. Global Endometrial Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Endometrial Cancer Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Endometrial Cancer Market Growth Strategy
Table 19. Main Points Interviewed from Key Endometrial Cancer Players
Table 20. Global Endometrial Cancer Revenue by Players (2015-2020) (Million US$)
Table 21. Global Endometrial Cancer Market Share by Players (2015-2020)
Table 22. Global Top Endometrial Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometrial Cancer as of 2019)
Table 23. Global Endometrial Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Endometrial Cancer Product Solution and Service
Table 26. Date of Enter into Endometrial Cancer Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Endometrial Cancer Market Size by Type (2015-2020) (Million US$)
Table 29. Global Endometrial Cancer Market Size Share by Type (2015-2020)
Table 30. Global Endometrial Cancer Revenue Market Share by Type (2021-2026)
Table 31. Global Endometrial Cancer Market Size Share by Application (2015-2020)
Table 32. Global Endometrial Cancer Market Size by Application (2015-2020) (Million US$)
Table 33. Global Endometrial Cancer Market Size Share by Application (2021-2026)
Table 34. North America Key Players Endometrial Cancer Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Endometrial Cancer Market Share (2019-2020)
Table 36. North America Endometrial Cancer Market Size by Type (2015-2020) (Million US$)
Table 37. North America Endometrial Cancer Market Share by Type (2015-2020)
Table 38. North America Endometrial Cancer Market Size by Application (2015-2020) (Million US$)
Table 39. North America Endometrial Cancer Market Share by Application (2015-2020)
Table 40. Europe Key Players Endometrial Cancer Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Endometrial Cancer Market Share (2019-2020)
Table 42. Europe Endometrial Cancer Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Endometrial Cancer Market Share by Type (2015-2020)
Table 44. Europe Endometrial Cancer Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Endometrial Cancer Market Share by Application (2015-2020)
Table 46. China Key Players Endometrial Cancer Revenue (2019-2020) (Million US$)
Table 47. China Key Players Endometrial Cancer Market Share (2019-2020)
Table 48. China Endometrial Cancer Market Size by Type (2015-2020) (Million US$)
Table 49. China Endometrial Cancer Market Share by Type (2015-2020)
Table 50. China Endometrial Cancer Market Size by Application (2015-2020) (Million US$)
Table 51. China Endometrial Cancer Market Share by Application (2015-2020)
Table 52. Japan Key Players Endometrial Cancer Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Endometrial Cancer Market Share (2019-2020)
Table 54. Japan Endometrial Cancer Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Endometrial Cancer Market Share by Type (2015-2020)
Table 56. Japan Endometrial Cancer Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Endometrial Cancer Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Endometrial Cancer Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Endometrial Cancer Market Share (2019-2020)
Table 60. Southeast Asia Endometrial Cancer Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Endometrial Cancer Market Share by Type (2015-2020)
Table 62. Southeast Asia Endometrial Cancer Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Endometrial Cancer Market Share by Application (2015-2020)
Table 64. India Key Players Endometrial Cancer Revenue (2019-2020) (Million US$)
Table 65. India Key Players Endometrial Cancer Market Share (2019-2020)
Table 66. India Endometrial Cancer Market Size by Type (2015-2020) (Million US$)
Table 67. India Endometrial Cancer Market Share by Type (2015-2020)
Table 68. India Endometrial Cancer Market Size by Application (2015-2020) (Million US$)
Table 69. India Endometrial Cancer Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Endometrial Cancer Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Endometrial Cancer Market Share (2019-2020)
Table 72. Central & South America Endometrial Cancer Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Endometrial Cancer Market Share by Type (2015-2020)
Table 74. Central & South America Endometrial Cancer Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Endometrial Cancer Market Share by Application (2015-2020)
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Product
Table 79. Pfizer Revenue in Endometrial Cancer Business (2015-2020) (Million US$)
Table 80. Pfizer Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Product
Table 84. Johnson & Johnson Revenue in Endometrial Cancer Business (2015-2020) (Million US$)
Table 85. Johnson & Johnson Recent Development
Table 86. Boston Scientific Company Details
Table 87. Boston Scientific Business Overview
Table 88. Boston Scientific Product
Table 89. Boston Scientific Revenue in Endometrial Cancer Business (2015-2020) (Million US$)
Table 90. Boston Scientific Recent Development
Table 91. GE Company Details
Table 92. GE Business Overview
Table 93. GE Product
Table 94. GE Revenue in Endometrial Cancer Business (2015-2020) (Million US$)
Table 95. GE Recent Development
Table 96. Karl Storz Company Details
Table 97. Karl Storz Business Overview
Table 98. Karl Storz Product
Table 99. Karl Storz Revenue in Endometrial Cancer Business (2015-2020) (Million US$)
Table 100. Karl Storz Recent Development
Table 101. Koninklijke Philips Company Details
Table 102. Koninklijke Philips Business Overview
Table 103. Koninklijke Philips Product
Table 104. Koninklijke Philips Revenue in Endometrial Cancer Business (2015-2020) (Million US$)
Table 105. Koninklijke Philips Recent Development
Table 106. Celgene Company Details
Table 107. Celgene Business Overview
Table 108. Celgene Product
Table 109. Celgene Revenue in Endometrial Cancer Business (2015-2020) (Million US$)
Table 110. Celgene Recent Development
Table 111. Lupin Business Overview
Table 112. Lupin Product
Table 113. Lupin Company Details
Table 114. Lupin Revenue in Endometrial Cancer Business (2015-2020) (Million US$)
Table 115. Lupin Recent Development
Table 116. LiNA Medical Company Details
Table 117. LiNA Medical Business Overview
Table 118. LiNA Medical Product
Table 119. LiNA Medical Revenue in Endometrial Cancer Business (2015-2020) (Million US$)
Table 120. LiNA Medical Recent Development
Table 121. Bayer AG Company Details
Table 122. Bayer AG Business Overview
Table 123. Bayer AG Product
Table 124. Bayer AG Revenue in Endometrial Cancer Business (2015-2020) (Million US$)
Table 125. Bayer AG Recent Development
Table 126. Cooper Surgical Company Details
Table 127. Cooper Surgical Business Overview
Table 128. Cooper Surgical Product
Table 129. Cooper Surgical Revenue in Endometrial Cancer Business (2015-2020) (Million US$)
Table 130. Cooper Surgical Recent Development
Table 131. Hologic Company Details
Table 132. Hologic Business Overview
Table 133. Hologic Product
Table 134. Hologic Revenue in Endometrial Cancer Business (2015-2020) (Million US$)
Table 135. Hologic Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endometrial Cancer Market Share by Type: 2020 VS 2026
Figure 2. Hysterectomy Techniques Features
Figure 3. Radiation Features
Figure 4. Hormone Therapy Features
Figure 5. Chemotherapy Features
Figure 6. Global Endometrial Cancer Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Gynecology Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Endometrial Cancer Report Years Considered
Figure 12. Global Endometrial Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Endometrial Cancer Market Share by Regions: 2020 VS 2026
Figure 14. Global Endometrial Cancer Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Endometrial Cancer Market Share by Players in 2019
Figure 17. Global Top Endometrial Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometrial Cancer as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Endometrial Cancer Revenue in 2019
Figure 19. North America Endometrial Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Endometrial Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Endometrial Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Endometrial Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Endometrial Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Endometrial Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Endometrial Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
子宮内膜生検ブラシの世界市場（～2026年） Market Analysis and Insights: Global Endometrial Biopsy Brush Market The global Endometrial Biopsy Brush market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Endometrial Biopsy Brush Scope and Market Size Endometrial Biopsy…- ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
- 膵臓がん治療の世界市場（～2026年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
- 転移性がん治療の世界市場（～2026年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
- 前立腺がんの世界市場（～2026年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Cancer Scope and Ma…